Core Viewpoint - The AI pharmaceutical technology developed by the company has positively impacted its business and performance, with substantial data supporting this claim [2] Group 1: Technology Impact - As of August 2025, the company's CADD/AIDD technology platform has provided technical support for 95 new drug projects, with 7 projects entering clinical trial stages [2] - The platform has served a total of 45 clients across various therapeutic areas, indicating its broad applicability and acceptance in the industry [2] Group 2: Strategic Importance - The technology platform represents a significant upgrade from traditional drug development to a more intelligent and systematic approach, becoming a core support for the company's new drug discovery strategic transformation [2]
泓博医药：CADD/AIDD技术平台已累计为95个新药项目提供技术支持，其中7个项目已进入临床实验